» Articles » PMID: 16880400

Phosphoinositide 3-kinase Regulatory Subunit P85alpha Suppresses Insulin Action Via Positive Regulation of PTEN

Overview
Specialty Science
Date 2006 Aug 2
PMID 16880400
Citations 82
Authors
Affiliations
Soon will be listed here.
Abstract

The phosphoinositide 3-kinase (PI3K) pathway is central to the metabolic actions of insulin on liver. Here, we show that mice with a liver-specific deletion of the p85alpha regulatory subunit of PI3K (L-Pik3r1KO) exhibit a paradoxical improvement of hepatic and peripheral insulin sensitivity. Although PI3K enzymatic activity is diminished in L-Pik3r1KO livers because of a reduced level of regulatory and catalytic subunits of PI3K, insulin-stimulated Akt activity is actually increased. This increased Akt activity correlates with increased phosphatidylinositol (3,4,5)-trisphosphate levels which are due, at least in part, to diminished activity of the (3,4,5)-trisphosphate phosphatase PTEN. Thus, the regulatory subunit p85alpha is a critical modulator of insulin sensitivity in vivo not only because of its effects on PI3K activation, but also as a regulator of PTEN activity.

Citing Articles

PI3KR1 and AKT1 in largemouth bass (Micropterus salmoides): molecular cloning, characterization, and its involvement in the alleviation of hepatic glycogen deposition caused by insulin inclusion in vitro.

Li Y, Chen S, Liu Y, Liu P, Li S, Liu N Fish Physiol Biochem. 2024; 50(6):2373-2388.

PMID: 39150597 DOI: 10.1007/s10695-024-01379-6.


Divergent roles of the regulatory subunits of class IA PI3K.

Kim C, Lee J, Park S Front Endocrinol (Lausanne). 2024; 14:1152579.

PMID: 38317714 PMC: 10839044. DOI: 10.3389/fendo.2023.1152579.


Molecular Insight into the Pharmacological Potential of Leaf Extract for Type-2 Diabetes Management Using the Network Pharmacology Approach.

Fatimawali , Tallei T, Johnson Kepel B, Bodhi W, Manampiring A, Nainu F Medicina (Kaunas). 2023; 59(11).

PMID: 38003949 PMC: 10673377. DOI: 10.3390/medicina59111899.


The Role of PIK3R1 in Metabolic Function and Insulin Sensitivity.

Tsay A, Wang J Int J Mol Sci. 2023; 24(16).

PMID: 37628845 PMC: 10454413. DOI: 10.3390/ijms241612665.


Insulin Regulation of Hepatic Lipid Homeostasis.

Uehara K, Santoleri D, Garcia Whitlock A, Titchenell P Compr Physiol. 2023; 13(3):4785-4809.

PMID: 37358513 PMC: 10760932. DOI: 10.1002/cphy.c220015.


References
1.
Cai D, Yuan M, Frantz D, Melendez P, Hansen L, Lee J . Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med. 2005; 11(2):183-90. PMC: 1440292. DOI: 10.1038/nm1166. View

2.
Taniguchi C, Ueki K, Kahn R . Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism. J Clin Invest. 2005; 115(3):718-27. PMC: 548317. DOI: 10.1172/JCI23187. View

3.
Bandyopadhyay G, Yu J, Ofrecio J, Olefsky J . Increased p85/55/50 expression and decreased phosphotidylinositol 3-kinase activity in insulin-resistant human skeletal muscle. Diabetes. 2005; 54(8):2351-9. DOI: 10.2337/diabetes.54.8.2351. View

4.
Virkamaki A, Ueki K, Kahn C . Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J Clin Invest. 1999; 103(7):931-43. PMC: 408269. DOI: 10.1172/JCI6609. View

5.
Backer J, Myers Jr M, Shoelson S, Chin D, Sun X, Miralpeix M . Phosphatidylinositol 3'-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J. 1992; 11(9):3469-79. PMC: 556882. DOI: 10.1002/j.1460-2075.1992.tb05426.x. View